The FDA is seeking public comment regarding the availability of scientific data and information regarding Cannabis or Cannabis derived ingredients. This has been a difficult topic for FDA considering the fact that such products are still classified as Schedule I substances at a Federal level. FDA is looking for scientific information to help them determine if there is a path
…